Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Synergistic Effect
100%
Neurodegeneration
100%
Cognitive Decline
100%
Alzheimer's Disease
18%
Neuroimaging Markers
12%
Practice Effects
12%
Secondary Prevention Trials
12%
Disease Stage
6%
High Risk
6%
Alzheimer's Disease Pathology
6%
Odds Ratio
6%
Magnetic Resonance Imaging
6%
Academic Medical Centers
6%
Positron Emission Tomography
6%
Sporadic Alzheimer's Disease
6%
Glucose Metabolism
6%
Neuropsychological Tests
6%
Hippocampal Volume
6%
F-18
6%
Cognitive Performance
6%
Imaging Marker
6%
Interaction Terms
6%
Cognitive Outcome
6%
Natural History Study
6%
Longitudinal Cognitive Decline
6%
Pittsburgh Compound B Positron Emission Tomography
6%
Fludeoxyglucose
6%
Vulnerable Regions
6%
Performance Practice
6%
Medicine and Dentistry
Neurodegeneration
100%
Amyloid Protein
100%
Cognitive Decline
100%
Alzheimer's Disease
31%
Secondary Prevention
12%
Positron Emission Tomography
12%
Glucose Metabolism
6%
Magnetic Resonance Imaging
6%
Hippocampus
6%
Neuropsychological Test
6%
Fluorine-18
6%
Pittsburgh Compound B
6%
Odds Ratio
6%
Biochemistry, Genetics and Molecular Biology
Positron Emission Tomography
100%
Amyloid Protein
100%
Glucose Metabolism
50%
Pittsburgh Compound B
50%
Magnetic Resonance Imaging
50%
Psychology
Alzheimer's Disease
100%
Cognitive Decline
100%
Neuroimaging
40%
Positron-Emission Tomography
40%
Magnetic Resonance Imaging
20%
Cognitive Performance
20%
Hippocampus
20%
Neuroscience
Neurodegeneration
100%
Amyloid Protein
100%
Alzheimer's Disease
31%
Positron Emission Tomography
12%
Magnetic Resonance Imaging
6%
Hippocampus
6%
Metabolic Pathway
6%
Fluorine-18
6%
Neuropsychological Test
6%